Cash Flow from Operating Activities: A company's cash flows from operations.
Olema Pharmaceuticals, Inc. (OLMA) had Cash Flow from Operating Activities of $-108.39M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-42.22M |
|
-- |
|
-- |
|
$45.88M |
|
$-45.88M |
|
$3.66M |
|
$-42.22M |
|
$-42.22M |
|
$-42.22M |
|
$-42.22M |
|
$-42.22M |
|
$-42.22M |
|
$-45.88M |
|
$-45.83M |
|
85.73M |
|
85.73M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$334.33M |
|
-- |
|
$18.12M |
|
$352.45M |
|
$41.66M |
|
$3.00M |
|
$3.31M |
|
$44.97M |
|
$307.49M |
|
$307.49M |
|
$307.49M |
|
68.65M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-108.39M |
$6.42M |
|
$-2.25M |
|
$139.48M |
|
$35.26M |
|
$-104.22M |
|
$13.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.03 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-108.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.73% |
|
-13.73% |
|
-11.98% |
|
-13.60% |
|
$4.48 |
|
$-1.26 |
|
$-1.26 |
|